<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:37:42Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10606374" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10606374</identifier>
        <datestamp>2023-10-28</datestamp>
        <setSpec>ijerph</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Environ Res Public Health</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Environ Res Public Health</journal-id>
              <journal-id journal-id-type="publisher-id">ijerph</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Environmental Research and Public Health</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1661-7827</issn>
              <issn pub-type="epub">1660-4601</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10606374</article-id>
              <article-id pub-id-type="pmcid">PMC10606374</article-id>
              <article-id pub-id-type="pmc-uid">10606374</article-id>
              <article-id pub-id-type="pmid">37887696</article-id>
              <article-id pub-id-type="pmid">37887696</article-id>
              <article-id pub-id-type="doi">10.3390/ijerph20206958</article-id>
              <article-id pub-id-type="publisher-id">ijerph-20-06958</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The Effect of Lower Limb Combined Neuromuscular Electrical Stimulation on Skeletal Muscle Signaling for Glucose Utilization, Myofiber Distribution, and Metabolic Function after Spinal Cord Injury</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0008-7260-5486</contrib-id>
                  <name>
                    <surname>Alharbi</surname>
                    <given-names>Amal</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <xref rid="af1-ijerph-20-06958" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Jia</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="af2-ijerph-20-06958" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Womack</surname>
                    <given-names>Erika</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="af3-ijerph-20-06958" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0300-5141</contrib-id>
                  <name>
                    <surname>Farrow</surname>
                    <given-names>Matthew</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="af2-ijerph-20-06958" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yarar-Fisher</surname>
                    <given-names>Ceren</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <xref rid="af2-ijerph-20-06958" ref-type="aff">2</xref>
                  <xref rid="af4-ijerph-20-06958" ref-type="aff">4</xref>
                  <xref rid="c1-ijerph-20-06958" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Nakamura</surname>
                    <given-names>Masatoshi</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-ijerph-20-06958"><label>1</label>Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL 35233, USA; <email>amal9@uab.edu</email></aff>
              <aff id="af2-ijerph-20-06958"><label>2</label>Department of Physical Medicine and Rehabilitation, Ohio State University, Columbus, OH 43210, USA; <email>jia.li@osumc.edu</email> (J.L.); <email>matthew.farrow@osumc.edu</email> (M.F.)</aff>
              <aff id="af3-ijerph-20-06958"><label>3</label>Department of Biochemistry, Molecular Biology, Entomology and Plant Pathology, Mississippi State University, Starkville, MS 39762, USA; <email>ewomack@mscl.msstate.edu</email></aff>
              <aff id="af4-ijerph-20-06958"><label>4</label>Department of Neuroscience, Ohio State University, Columbus, OH 43210, USA</aff>
              <author-notes>
                <corresp id="c1-ijerph-20-06958"><label>*</label>Correspondence: <email>yarar-fisher.1@osu.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>10</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>10</month>
                <year>2023</year>
              </pub-date>
              <volume>20</volume>
              <issue>20</issue>
              <elocation-id>6958</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>8</month>
                  <year>2023</year>
                </date>
                <date date-type="rev-recd">
                  <day>29</day>
                  <month>9</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>12</day>
                  <month>10</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 by the authors.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Maintaining healthy myofiber type and metabolic function early after spinal cord injury (SCI) may prevent chronic metabolic disorders. This study compares the effects of a 2–5 week combined (aerobic + resistance) neuromuscular electrical stimulation (Comb-NMES) regimen versus a sham control treatment on muscle protein signaling for glucose uptake, myofiber type distribution, and metabolic function. Twenty participants (31 ± 9 years of age) with an SCI (C4-L1, AIS level A–C) within 14 days of the SCI were randomly assigned to control (<italic toggle="yes">N</italic> = 8) or Comb-NMES (<italic toggle="yes">N</italic> = 12). Sessions were given three times per week. Fasting blood samples and vastus lateralis muscle biopsies were collected 24–48 h before or after the last session. Western blots were performed to quantify proteins, immunohistochemical analyses determined muscle myofiber distribution, and enzymatic assays were performed to measure serum glucose, insulin, and lipids. Our main findings include a decrease in fasting glucose (<italic toggle="yes">p</italic> &lt; 0.05) and LDL-C (<italic toggle="yes">p</italic> &lt; 0.05) levels, an upregulation of CamKII and Hexokinase (<italic toggle="yes">p</italic> &lt; 0.05), and an increase in type I (+9%) and a decrease in type IIx (−36%) myofiber distribution in response to Comb-NMES. Our findings suggest that maintaining healthy myofiber type and metabolic function may be achieved via early utilization of Comb-NMES.</p>
              </abstract>
              <kwd-group>
                <kwd>spinal cord injury</kwd>
                <kwd>neuromuscular electrical stimulation</kwd>
                <kwd>metabolic function</kwd>
                <kwd>myofiber type</kwd>
                <kwd>muscle glucose uptake</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development</funding-source>
                  <award-id>K01HD087463</award-id>
                </award-group>
                <funding-statement>This research was funded by the Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development, federal award identification number K01HD087463. </funding-statement>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-ijerph-20-06958">
              <title>1. Introduction</title>
              <p>The prevalence of metabolic disorders (e.g., type 2 diabetes, impaired glucose tolerance, and abnormal lipid profiles) is higher in those with spinal cord injury (SCI) vs. age- and sex-matched non-injured individuals [<xref rid="B1-ijerph-20-06958" ref-type="bibr">1</xref>,<xref rid="B2-ijerph-20-06958" ref-type="bibr">2</xref>]. Individuals with SCI have an accelerated trajectory of metabolic disorders [<xref rid="B3-ijerph-20-06958" ref-type="bibr">3</xref>,<xref rid="B4-ijerph-20-06958" ref-type="bibr">4</xref>,<xref rid="B5-ijerph-20-06958" ref-type="bibr">5</xref>], with chronic disease states occurring at an earlier age compared with non-injured individuals. These chronic diseases may worsen the substantial declines in functional independence, psychological well-being, and quality of life that occur following an SCI [<xref rid="B3-ijerph-20-06958" ref-type="bibr">3</xref>].</p>
              <p>In healthy humans, up to 70% of whole-body glucose metabolism occurs in skeletal muscle. The regulation of glucose homeostasis is dependent on a finely balanced relationship between (i) muscle sensitivity to insulin and (ii) insulin secretion [<xref rid="B4-ijerph-20-06958" ref-type="bibr">4</xref>,<xref rid="B5-ijerph-20-06958" ref-type="bibr">5</xref>]. However, following an SCI, the activation and loading levels of skeletal muscle below the level of the lesion are absent or extremely reduced. Without preventive measures, muscle atrophy rapidly occurs and results in a decline in functional capacity. The cross-sectional area of the lower limb muscles is substantially smaller (25–45%) than in non-injured controls at 6 weeks post-injury [<xref rid="B6-ijerph-20-06958" ref-type="bibr">6</xref>,<xref rid="B7-ijerph-20-06958" ref-type="bibr">7</xref>]. In addition to fiber atrophy, muscle protein changes occur within several months after an SCI, which ultimately produces a muscle fiber type that is highly fatigable and contains a high proportion of glycolytic fibers that are characterized by a lower resistance to fatigue and impaired oxidative capacity and mitochondrial function [<xref rid="B8-ijerph-20-06958" ref-type="bibr">8</xref>,<xref rid="B9-ijerph-20-06958" ref-type="bibr">9</xref>,<xref rid="B10-ijerph-20-06958" ref-type="bibr">10</xref>,<xref rid="B11-ijerph-20-06958" ref-type="bibr">11</xref>]. This fiber transformation results in muscle tissue that is insulin-resistant and metabolically inflexible. The muscles of individuals with SCI have similar histochemical and biochemical properties to those with diabetes. This includes fewer type I fibers and a greater proportion of glycolytic (type IIax and IIx) fibers [<xref rid="B12-ijerph-20-06958" ref-type="bibr">12</xref>]. The glucose handling capacity is impaired due to lower levels of key enzymes, namely glucose transporter 4 (GLUT 4), hexokinase II, glycogen synthase, and pyruvate dehydrogenase-E1α. This downregulation of GLUT4 expression has been associated with lower whole-body glucose tolerance and insulin sensitivity in individuals with chronic SCI [<xref rid="B12-ijerph-20-06958" ref-type="bibr">12</xref>].</p>
              <p>These observations support the idea that rather than attempting to reverse changes in the sub-acute or chronic stage of SCI, early interventions are likely to more effective in the prevention of deleterious muscle adaptations. One potential and promising strategy to improve skeletal muscle metabolism is neuromuscular electrical stimulation (NMES). NMES-resistance training has been shown to increase the size and distribution (type IIa) of myofibers [<xref rid="B13-ijerph-20-06958" ref-type="bibr">13</xref>]. However, the distribution of type I fibers did not increase after eight weeks. This highlights the need for an NMES program that produces key adaptations akin to resistance and aerobic exercise to maintain a muscle phenotype that is fatigue-resistant, insulin-sensitive, and oxidative.</p>
              <p>To identify effective strategies for improving metabolic profiles among individuals with SCI, we aimed to test the impact of an early intervention (14 days after SCI) of a combined (aerobic + resistance) NMES (Comb-NMES) intervention on muscle growth and type distribution, signaling processes involved in muscle glucose uptake, and systemic metabolic responses. We tested the following hypotheses: (1) Comb-NMES will effectively upregulate signaling proteins that promote GLUT-4 translocation; and (2) Comb-NMES will maintain greater muscle size and a healthy muscle fiber phenotype (similar distribution of type I, IIa, and IIx fibers); and (3) Comb-NMES will produce beneficial changes in serum glucose, insulin, and lipid levels.</p>
            </sec>
            <sec id="sec2-ijerph-20-06958">
              <title>2. Materials and Methods</title>
              <sec sec-type="subjects" id="sec2dot1-ijerph-20-06958">
                <title>2.1. Participants and Study Design</title>
                <p>In a randomized, controlled study design, participants with acute SCI were randomly assigned into intervention or sham-control groups in a 1:1 ratio. 20 individuals (3 F and 17 M; 31 ± 9 years of age; 12 Comb-NMES and 8 controls) with SCI (injury levels: C4-L1 American Spinal Injury Association Impairment Scale (AIS) A–C), within 14 days of the injury, medically stable at the time of testing, with no history of metabolic syndrome and/or type 1 or type 2 diabetes, completed the study (participant characteristics displayed in <xref rid="ijerph-20-06958-t001" ref-type="table">Table 1</xref>). The only medication that was self-reported in either group was anti-spasticity medication (Baclofen). Outcome measures were taken at two time points: (1) during inpatient rehabilitation (IPR) within the first 14 days of injury and within week 1 of initial rehab; and (2) pre-discharge at week 4 or 5. The Comb-NMES group received a Comb-NMES exercise, and the control group received a sham exercise in addition to their IPR standard care. Standard care included respiration therapy, bowel and bladder management, tone and spasticity management, bed mobility, transfers, wheelchair mobility skills, and skills for performing activities of daily living.</p>
              </sec>
              <sec id="sec2dot2-ijerph-20-06958">
                <title>2.2. Interventions</title>
                <sec id="sec2dot2dot1-ijerph-20-06958">
                  <title>2.2.1. Comb-NMES Intervention</title>
                  <p>Comb-NMES included NMES-resistance exercise and NMES-aerobic exercise three days per week (M, W, and F), separated by a rest day. NMES resistance required concentric and eccentric quadricep contractions while seated. Each session had four sets of ten repetitions that were elicited using 450 µs biphasic pulses at 50 Hz. Surface NMES was used to carry out the protocol. Tetanic muscular contractions that evoke complete knee extension were induced by raising the current from zero to the goal level (50–200 mA) in 3 to 5 s. Following the production of the knee extension, the current was quickly reduced (an additional 3–5 s) to allow for progressive relaxation into a flexed position. There was normally a 5 min break between sets because both legs were worked in an alternating fashion [<xref rid="B13-ijerph-20-06958" ref-type="bibr">13</xref>,<xref rid="B14-ijerph-20-06958" ref-type="bibr">14</xref>,<xref rid="B15-ijerph-20-06958" ref-type="bibr">15</xref>]. The weights were progressively increased by 2 lb. on a weekly basis after achieving 40 repetitions of full knee extension in a session. If participants failed to obtain full knee extension for 4 sets of 10 repetitions, the same load was maintained until the desired repetitions were achieved. During the first week, ankle weights were not used to ensure full knee extension against gravity and to prevent skeletal muscle damage [<xref rid="B16-ijerph-20-06958" ref-type="bibr">16</xref>,<xref rid="B17-ijerph-20-06958" ref-type="bibr">17</xref>]. The current amplitude of electrical stimulation was monitored for each repetition to ensure that the increase in weight lifted was a result of muscle adaptations and not increased electrical stimulation current amplitudes (<xref rid="ijerph-20-06958-f001" ref-type="fig">Figure 1</xref>A). Upon completion of each NMES-RE session, participants were given a short break (10–15 min) for recovery before starting aerobic training. NMES aerobic exercise involved twitch electrical stimulation (pulse duration/interval = 200/50 µs) applied to the quadriceps muscle via surface NMES. The current amplitude was set to 100–200 mA [<xref rid="B18-ijerph-20-06958" ref-type="bibr">18</xref>] and kept consistent for each patient. The training started with 10 min of twitch stimulation at 2 Hz. After the first week, the duration of the session was progressively increased to 60 min at 10 Hz (<xref rid="ijerph-20-06958-f001" ref-type="fig">Figure 1</xref>B).</p>
                </sec>
                <sec id="sec2dot2dot2-ijerph-20-06958">
                  <title>2.2.2. Sham Intervention</title>
                  <p>This group received standard care plus passive dynamic exercise of the lower legs (sham treatment for NMES-RE) and transcutaneous electrical nerve stimulation (TENS, sham treatment for NMES-aerobic exercise) during IPR. For the passive dynamic lower leg exercise, a physical therapist passively moved the participant’s lower leg to a full knee extension and flexion for a similar duration used for NMES-RE (3–5 s to attain knee extension and flexion). Both legs were trained in an alternating order with 5 min of rest between sets. Upon completion of leg exercises, participants were given a short break (10–15 min) for recovery before starting the TENS intervention. For TENS, we applied 1/4 of the current needed to aerobically train the muscle. For example, 100–200 mA is typically needed to adequately stimulate the paralyzed muscle with long-standing SCI; thus, 25–50 mA with a pulse duration/interval of 200/50 µs was used as the control stimulus [<xref rid="B8-ijerph-20-06958" ref-type="bibr">8</xref>]. This protocol allowed some current to flow; however, it did not result in visible muscle contractions. All participants in both groups were either trained in their wheelchairs or beds.</p>
                </sec>
              </sec>
              <sec sec-type="methods" id="sec2dot3-ijerph-20-06958">
                <title>2.3. Clinical and Laboratory Procedures</title>
                <sec id="sec2dot3dot1-ijerph-20-06958">
                  <title>2.3.1. Muscle Biopsy</title>
                  <p>Our lab’s established percutaneous needle biopsy technique was used to obtain samples from the vastus lateralis [<xref rid="B18-ijerph-20-06958" ref-type="bibr">18</xref>,<xref rid="B19-ijerph-20-06958" ref-type="bibr">19</xref>]. Biopsies were carried out utilizing a 5-mm Bergstrom-type biopsy needle while under local anesthesia (1% lidocaine). For immunohistochemistry, 50–70 mg of muscle was mounted cross-sectionally and frozen in liquid nitrogen-cooled isopentane. For upcoming biochemical tests, the remaining tissue was snap-frozen in 30 mg pieces. The list of primary and secondary antibodies used in the fluorescent immunohistochemistry and immunoblotting appeared in <xref rid="ijerph-20-06958-t002" ref-type="table">Table 2</xref>.</p>
                </sec>
                <sec id="sec2dot3dot2-ijerph-20-06958">
                  <title>2.3.2. Myofiber-Type Distribution</title>
                  <p>The relative distributions of myofiber types I, IIa, and IIax/IIx were determined immunohistochemically using our laboratory’s well-established protocol [<xref rid="B20-ijerph-20-06958" ref-type="bibr">20</xref>]. Briefly, at −20 °C, the frozen muscle mounts were sliced into 6 µm cross-sections using a Leica CM1860 cryostat chamber (Deer Park, IL, USA). Sections were cut in triplicates and mounted on three-well slides (Electron Microscopy Sciences, Hatfield, PA, USA) before IHC staining. Cryostat sections were air-dried at room temperature for 30 min before being kept in a humidified chamber throughout the staining protocol. NCL-MHCs (anti-MHC I) and NCL-MHCf (anti-MHC II) primary antibodies were obtained from Leica Biosystems (Deerfield, IL), and anti-laminin antibodies were obtained from Sigma-Aldrich (St. Louis, MO, USA). Thermo Fisher Scientific (Norcross, GA, USA) provided secondary antibodies, ALEXA Fluor 594 (red fluorescent dye) and 488 (bright green fluorescent dye), and 3% neutral-buffered formalin. According to the manufacturer’s instructions, primary and secondary antibodies were diluted in 1% goat serum. Tissue sections were fixed for 30 min in 3% neutral-buffered formalin. To decrease non-specific background staining, sections were blocked with 5% goat serum prior to the application of primary and secondary antibodies and washed 3× for 5 min with ice-cold 1x phosphate-buffered saline (PBS; pH = 7.4). ALEXA Fluor 594 (MHC type I, slow) and 488 (MHC type II, rapid) were used to stain the fiber types. The anti-laminin antibody was co-stained with ALEXA Fluor 488 to enable observation of fiber boundaries and myofiber size. Sections mounted with Vectashield mounting fluid containing DAPI (Vector Laboratories, Burlingame, CA, USA) created a blue fluorescence that allowed nuclei to be identified. Slides and coverslips were bonded together with nail varnish and kept at −20 °C until microscopy. In the present study, we pooled hybrid IIax fibers with type IIx fibers due to the high percentage of IIax myofibers found in the samples. For the Comb-NMES group, myofiber type distribution was determined for 7641 (min: 256, max: 1328) VL myofibers pre-training and for 6978 (min: 379, max: 1355) VL myofibers post-training. Myofiber-type distribution was determined for 4550 (min: 603, max: 1056) VL myofibers pre-training and 5164 (min: 309, max: 1618) VL myofibers post-training for the control group.</p>
                </sec>
                <sec id="sec2dot3dot3-ijerph-20-06958">
                  <title>2.3.3. Immunoblotting</title>
                  <p>Mixed muscle protein lysate was prepared using an established method in our laboratory [<xref rid="B21-ijerph-20-06958" ref-type="bibr">21</xref>]. We homogenized muscle samples (30 mg) after a 15 min preincubation in ice-cold lysis buffer with protease and phosphatase inhibitors and centrifuged them for 10 min at a temperature of 4 °C at 15,000× <italic toggle="yes">g</italic>. The supernatant was stored at −80 °C until assayed for protein quantity using the bicinchoninic acid technique with bovine serum albumin (BSA) as a standard.</p>
                  <p>Skeletal muscle total protein (20 µg) lysate was resolved on 4–12% SDS-PAGE gels using our laboratory protocol as described previously [<xref rid="B21-ijerph-20-06958" ref-type="bibr">21</xref>,<xref rid="B22-ijerph-20-06958" ref-type="bibr">22</xref>]. All gels contained samples from both the intervention and control groups loaded in series. The transfer of the proteins from the gels to the nitrocellulose membranes was performed using the Thermo Scientific Pierce Power Blotter preprogrammed transfer methods. Total lane normalization was achieved by obtaining imaging of the Ponceau S-stained membranes using the Bio-Rad ChemiDoc imaging system immediately after transfer to verify the total protein from each lane. The content and phosphorylation of proteins associated with skeletal muscle GLUT-4 translocation were assessed. The membranes were blocked for 60 min at room temperature in 5% non-fat milk in TBST (0.1% Tween 20 and 150 mM NaCl in 10 mM Tris-Base, pH 7.4) and probed overnight at 4 °C with the targeted primary antibody purchased from Thermo Scientific (Rockford, IL, USA) and Cell Signaling Technologies (Danvers, MA, USA) at a concentration of 1:1000 dilution in 5% BSA with TBST (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) against the following: GLUT-4 transporter total AMPK-α, phospho (Thr172)-AMPK-α, total CaMKII, total Akt, phospho (Thr286)-CaMKII, phospho (Thr642)-AS160, phospho (Ser473)-Akt, total AS160, Hexokinase II, Glycogen Synthase (GS), phospho (Ser641)-GS, IRS-1, and phospho (Tyr895)-IRS-1. Horseradish peroxidase-conjugated secondary antibodies were used at a concentration of 1:2500, followed by chemiluminescent detection (SuperSignal West Femto Chemiluminescent Substrate, Thermo Scientific, Rockford, IL, USA) in a BioRad ChemiDoc imaging system with band densitometry performed using BioRad Image Lab software (version 6.1). The density of the band was measured against the total lane background to obtain the normalized band volume.</p>
                </sec>
                <sec id="sec2dot3dot4-ijerph-20-06958">
                  <title>2.3.4. Determination of Blood Glucose, Insulin, and Lipids</title>
                  <p>All analyses took place at the UAB Nutrition Obesity Research Center-Metabolism Core. Serum glucose, total cholesterol, LDL, HDL, and triglycerides were assessed using an automated analyzer (Sirrus analyzer; Stanbio Laboratory, Boerne, TX, USA). LDL concentrations were calculated using the Friedwald method [<xref rid="B23-ijerph-20-06958" ref-type="bibr">23</xref>]. Serum insulin was measured using immunofluorescence with an AIA-600 II analyzer (TOSOH Bioscience, South San Francisco, CA, USA).</p>
                </sec>
              </sec>
              <sec id="sec2dot4-ijerph-20-06958">
                <title>2.4. Statistical Analysis</title>
                <p>Descriptive statistics for subjects’ characteristics were calculated with a mean ± standard deviation for normally distributed continuous variables. Median and interquartile range (IQR) are reported for non-normally distributed variables (i.e., duration). Normality was evaluated using the Shapiro-Wilk test. Unpaired <italic toggle="yes">t</italic>-tests and Mann-Whiteney U tests were used to compare age and duration between groups, respectively. Fisher’s exact test was used to compare baseline group characteristics for continuous and categorical variables, respectively. A linear mixed model analysis was constructed to test the effect of treatment, time, and their interaction on the participant as a random effect using the SAS 9.4 proc mixed procedure (SAS Institute, Inc., Cary, NC, USA). Outcomes of interest for the linear mixed-effects model include indices of glucose homeostasis (i.e., fasting glucose, insulin), lipid profile (i.e., total cholesterol, triacylglycerol, HDL-cholesterol, LDL-cholesterol), skeletal muscle proteins involved in GLUT4 translocation, and muscle fiber type distribution. Pairwise post hoc comparisons were performed using the Tukey–Kramer multiple comparisons method to estimate within-group changes within the linear mixed-effects model. Statistical model assumptions (e.g., homogeneity of variance, normal distribution of residuals) were confirmed before data analysis using the respective diagnostic plots. Statistical tests were two-sided, with <italic toggle="yes">p</italic> &lt; 0.05 considered statistically significant. Statistical analyses were performed using SAS, version 9.4 (SAS Institute, Inc.). Data are presented as means ± standard errors from the linear mixed-effects model unless otherwise stated. In the current report, due to the small sample size, we did not include covariates to avoid overfitting the statistical model. Furthermore, in our preliminary analysis, including age, level of injury, completeness, and duration of stay did not change our main observations. We could not obtain sufficient muscle samples from 5 individuals and blood samples from 6; therefore, final analyses were done on 15 people (Comb-NMES: 8 and control: 7) for muscle intracellular signaling and fiber-type and 14 (Comb-NMES: 8 and control: 6) for glucose, insulin, and lipid outcomes.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-ijerph-20-06958">
              <title>3. Results</title>
              <sec id="sec3dot1-ijerph-20-06958">
                <title>3.1. Participant Characteristics</title>
                <p>Participants’ demographic data are shown in <xref rid="ijerph-20-06958-t001" ref-type="table">Table 1</xref>. Overall, there were no significant differences between groups in terms of the distribution of factors such as level of injury, completeness, injury type, gender, and race. The median duration of intervention for the control and Comb-NMES groups was 18 and 21 days, respectively (<italic toggle="yes">p</italic> = 0.38). The mean age of participants in the Comb-NMES group was higher than that of the control group (age difference: 9.8 years, <italic toggle="yes">p</italic> = 0.01). The average intensity delivered in the Dudley and Twitch protocols in the Comb-NMES group was 123.8 mA, ±45.2, and 118.2 mA, ±44.2, respectively. In addition, the average repetition was given in the Dudley protocol as 9 ± 2 reps.</p>
              </sec>
              <sec id="sec3dot2-ijerph-20-06958">
                <title>3.2. Glucose Homeostasis (N = 14)</title>
                <p>A significant time effect in fasting glucose concentration was observed, where fasting glucose concentrations decreased over time regardless of the treatment group (<italic toggle="yes">p</italic> &lt; 0.05 for time effect). However, there was no interaction (group × time) effect (<italic toggle="yes">p</italic> = 0.15). Post hoc analysis showed that the changes were significant (−19.9 mg/dL, <italic toggle="yes">p</italic> = 0.01) in Comb-NMES but not significant in the control group (−7.3 mg/dL, <italic toggle="yes">p</italic> &gt; 0.05; <xref rid="ijerph-20-06958-f002" ref-type="fig">Figure 2</xref>A). Similarly, a significant time effect was observed for fasting insulin, where insulin decreased over time regardless of the treatment group (<xref rid="ijerph-20-06958-f002" ref-type="fig">Figure 2</xref>B; <italic toggle="yes">p</italic> &lt; 0.05 for time effect). Changes in fasting insulin within each group were not significant.</p>
              </sec>
              <sec id="sec3dot3-ijerph-20-06958">
                <title>3.3. Lipid Profile (N = 14)</title>
                <p>There were no changes in total cholesterol, triacylglycerol, or HDL (<xref rid="ijerph-20-06958-f003" ref-type="fig">Figure 3</xref>A–C). A significant interaction (group × time) effect was found for LDL cholesterol (<italic toggle="yes">p</italic> &lt; 0.05). The interaction effect was driven by a decrease in LDL cholesterol for the Comb-NMES group (pre: 109.8 mg/dL vs. post: 89.3 mg/dL) and an increase in the control group (pre: 78.5 mg/dL vs. post: 92 mg/dL; <xref rid="ijerph-20-06958-f003" ref-type="fig">Figure 3</xref>D), though only the changes in the Comb-NMES were statistically significant (<italic toggle="yes">p</italic> = 0.01).</p>
              </sec>
              <sec id="sec3dot4-ijerph-20-06958">
                <title>3.4. Skeletal Muscle Intracellular Signaling (N = 15)</title>
                <p>All of the putative proteins and their relevant phosphorylation involved in the GLUT4 translocation pathway did not change differently over time between groups except for the phosphorylation of GS_Ser641. Phosphorylation of GS_Ser641 decreased in the Comb-NMES group and increased in the control group (interaction: <italic toggle="yes">p</italic> &lt; 0.05; changes within each group were not statistically significant, <xref rid="ijerph-20-06958-f004" ref-type="fig">Figure 4</xref>B). CamKII, AKT, pAKT_Ser473, and Hexokinase II increased over time regardless of treatment group (time: <italic toggle="yes">p</italic> &lt; 0.05, <xref rid="ijerph-20-06958-f004" ref-type="fig">Figure 4</xref>C,E–G). There was a tendency towards a time effect for Glut4 (time: <italic toggle="yes">p</italic> = 0.07) and IRS-1 (time: <italic toggle="yes">p</italic> = 0.08; <xref rid="ijerph-20-06958-f004" ref-type="fig">Figure 4</xref>H–I), where Glut4 and IRS-1 increased over time. Despite the lack of interaction effect, the increase for some of these proteins was higher in the Comb-NMES group. For example, there was a 170% increase in Hexokinase II in the Comb-NMES (<italic toggle="yes">p</italic> &lt; 0.05) group after the intervention compared with a 22% increase in the control group. There was a 67%, 49%, 133%, 63%, and 32% increase in CamKII (<italic toggle="yes">p</italic> &lt; 0.05), Glut4, IRS-1, AS160, and GS in the Comb-NMES group after the intervention, compared with a 16%, 36%, 14%, 3%, and 17% increase in the control group, respectively. Representative immunoblots of the skeletal muscle intracellular signaling proteins are presented in <xref rid="ijerph-20-06958-f005" ref-type="fig">Figure 5</xref>. Additional immunoblots can be found in the <xref rid="app1-ijerph-20-06958" ref-type="app">supplementary</xref>.</p>
              </sec>
              <sec id="sec3dot5-ijerph-20-06958">
                <title>3.5. Myofiber-Type Distribution (N = 15)</title>
                <p>There was no effect of intervention, time, or their interaction on myofiber type distribution (<xref rid="ijerph-20-06958-f006" ref-type="fig">Figure 6</xref>). However, MHCI increased by 9% in the Comb-NMES group compared with a 12% reduction in the control group. In addition, MHC IIx decreased by 36% in the Comb-NMES group compared with a 67% increase in the control group.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-ijerph-20-06958">
              <title>4. Discussion</title>
              <p>People with SCI are more susceptible to type II diabetes, obesity, and cardiovascular disease compared with age- and sex-matched non-injured individuals [<xref rid="B1-ijerph-20-06958" ref-type="bibr">1</xref>,<xref rid="B2-ijerph-20-06958" ref-type="bibr">2</xref>]. Maintaining sufficient muscle mass and metabolic function is likely to be a potent strategy to prevent a decline in cardiometabolic health in individuals with SCI. Implementing an early intervention to prevent these deleterious adaptations may work more effectively than attempting to reverse changes several months or years after SCI. Therefore, our objectives were to test the impact of early intervention (14 days after SCI) of a Comb-NMES intervention on muscle growth and type distribution, signaling processes that regulate muscle glucose uptake, and systemic metabolic responses. This is the first study to use a novel Comb-NMES approach coupling electrically induced resistance and aerobic exercise on the knee extensor muscle group (quadriceps) to maintain or even improve muscle and systemic metabolic function. The primary and novel findings are that Comb-NMES intervention resulted in more notable increases in total protein levels of IRS-1 (+133% vs. +14%), CamKII (+67% vs. +16%), Hexokinase II (+170% vs. +22%), and GS (+37% vs. −24%). We also showed that Comb-NMES intervention successfully increased slow-oxidative type I fibers (+9%) and decreased fast-glycolytic type IIx fibers (−36%). On the other hand, slow-oxidative type I fibers decreased (−12%), and fast-glycolytic type IIx fibers increased (+67%) in response to the control intervention. In addition, there was a significant and more considerable decrease in fasting blood glucose levels in the Comb-NMES (<italic toggle="yes">p</italic> &lt; 0.05) compared with the control group (−19.9 mg/dL vs. −7.3 mg/dL). Although no changes were observed in total cholesterol, triglycerides, or HDL, LDL cholesterol significantly decreased in the Comb-NMES group (−20.5 mg/dL, <italic toggle="yes">p</italic> &lt; 0.05) compared with an increase in the control group (+13.5 mg/dL). These results attest to the robust systemic and muscle responses to Comb-NMES.</p>
              <sec id="sec4dot1-ijerph-20-06958">
                <title>4.1. Glucose, Insulin, and Lipid Profile</title>
                <p>Reduced fasting glucose (−19.9 mg/dL) and insulin levels (−11.29 mg/dL) in response to 2–5 weeks of Comb-NMES are promising for promoting glucose homeostasis in acute SCI. This finding agrees with our previous work in individuals with long-standing SCI [<xref rid="B24-ijerph-20-06958" ref-type="bibr">24</xref>] that demonstrated improvements in fasting glucose levels following an 8-week NMES-RT. Other studies [<xref rid="B2-ijerph-20-06958" ref-type="bibr">2</xref>,<xref rid="B24-ijerph-20-06958" ref-type="bibr">24</xref>] showed no effect of NMES-RT on fasting glucose and insulin levels in response to 12 to 16 weeks of NMES-RT. Given that previous interventions were significantly longer than the present intervention (12–16 weeks vs. 2–5 weeks) and used only RT as an intervention, repetitively stressing the muscle with low-frequency electrical stimulation (aerobic training) might be needed for marked improvements in glucose homeostasis. The type of skeletal muscle fibers affects insulin sensitivity throughout the body. A positive correlation exists between the proportion of type I fibers in muscle and whole-body insulin sensitivity in humans. When [<xref rid="B25-ijerph-20-06958" ref-type="bibr">25</xref>] type I fibers were predominant, human muscle strips showed greater insulin-stimulated glucose transport [<xref rid="B26-ijerph-20-06958" ref-type="bibr">26</xref>]. Hence, type I fibers are likely to play a greater role in maintaining glucose homeostasis in response to insulin than type II fibers. Furthermore, in humans, GLUT4 protein levels are highest in type I fibers (vs. IIa and IIx) [<xref rid="B27-ijerph-20-06958" ref-type="bibr">27</xref>,<xref rid="B28-ijerph-20-06958" ref-type="bibr">28</xref>]. These findings suggest insulin’s effect on glucose transport is highest in type I fibers. Our study found that type I fibers and GLUT-4 protein levels increased in response to Comb-NMES training. Therefore, the reduction in fasting glucose in the Comb-NMES group may be due to an increase in type I fibers.</p>
                <p>LDL-cholesterol is a well-established cardiovascular disease risk factor for cardiovascular disease, with evidence from large-scale epidemiological and Mendelian randomization studies [<xref rid="B29-ijerph-20-06958" ref-type="bibr">29</xref>,<xref rid="B30-ijerph-20-06958" ref-type="bibr">30</xref>]. LDL cholesterol levels significantly changed in both groups. It decreased in the Comb-NMES group (−20.5 mg/dL) and increased in the control group (+13 mg/dL, <xref rid="ijerph-20-06958-f003" ref-type="fig">Figure 3</xref>D). Our finding of reduced LDL cholesterol agrees with a previous study that demonstrated a reduction in LDL cholesterol (−7.2 mg/dL) in response to 12-week, twice-per-week NMES-RT [<xref rid="B31-ijerph-20-06958" ref-type="bibr">31</xref>]. Other studies have not shown marked changes in lipid profiles when administered NMES-RT combined with testosterone treatment [<xref rid="B32-ijerph-20-06958" ref-type="bibr">32</xref>] or home-based NMES endurance training for 16 weeks [<xref rid="B33-ijerph-20-06958" ref-type="bibr">33</xref>]. In addition, no change in lipid profile was reported with an 8-week, three times per week upper extremity aerobic exercise combined with NMES-RT in individuals with long-standing SCI [<xref rid="B24-ijerph-20-06958" ref-type="bibr">24</xref>]. Therefore, early intervention with Comb-NMES might be needed to reduce LDL cholesterol significantly. Although participants in this study did not present with cardiovascular disease risk factors, a 1-mmol/L (»18 mg/dL) reduction in LDL-C with statin therapy was associated with a 23% reduction in major vascular events in &gt;300,000 participants with major vascular events [<xref rid="B29-ijerph-20-06958" ref-type="bibr">29</xref>].</p>
              </sec>
              <sec id="sec4dot2-ijerph-20-06958">
                <title>4.2. Skeletal Muscle Intracellular Signaling</title>
                <p>The regulation of muscle glucose utilization consists of three serial steps: the delivery of glucose from the blood to the muscle membrane, the transport across the muscle membrane, and the phosphorylation of glucose-6-phosphate. Upon stimulation by insulin [<xref rid="B34-ijerph-20-06958" ref-type="bibr">34</xref>] or exercise [<xref rid="B35-ijerph-20-06958" ref-type="bibr">35</xref>], GLUT4 translocates to the sarcolemma, making it highly permeable to glucose. GLUT4 translocation lowers the barrier to glucose transport and, in effect, shifts the responsibility to glucose delivery, phosphorylation, and flux through muscle metabolism. We previously showed that GLUT-4 and IRS-1 total protein content was significantly lower in the resting muscles of individuals with long-standing SCI compared with age- and sex-matched non-injured individuals [<xref rid="B36-ijerph-20-06958" ref-type="bibr">36</xref>], suggesting a barrier in glucose transport across the muscle membrane. The total protein content for GLUT-4, IRS-1, Hexokinase II, CaMKII, and GS total protein content increased in the Comb-NMES group, suggesting that early and chronic exposure to Comb-NMES training improved both the insulin- and contraction-stimulated translocation of GLUT4 in the paralyzed muscle.</p>
                <p>The translocation of GLUT-4 is caused by muscle contractions caused by the activation of AMPK [<xref rid="B37-ijerph-20-06958" ref-type="bibr">37</xref>,<xref rid="B38-ijerph-20-06958" ref-type="bibr">38</xref>] and CaMK-mediated signaling pathways [<xref rid="B39-ijerph-20-06958" ref-type="bibr">39</xref>]. Additionally, insulin and contraction-induced GLUT-4 translation in skeletal muscle is mediated by AS160 [<xref rid="B40-ijerph-20-06958" ref-type="bibr">40</xref>]. However, we found no alteration in the overall protein levels of AMPK in the Comb-NMES group. This could be attributed to changes in the distribution of muscle fiber types. Previous studies have reported differences in AMPK activation between different fiber types at rest and after a single exercise session [<xref rid="B41-ijerph-20-06958" ref-type="bibr">41</xref>]. Resting AMPK phosphorylation seems to be the most significant in type IIa fibers, while a single exercise session leads to increased AMPK phosphorylation in all fibers, particularly type IIx fibers. Therefore, the absence of changes in AMPK observed in our study may be due to an increase in type I fibers and a decrease in type IIx fibers in response to Comb-NMES. Previous research suggests that the increase in cytosolic Ca<sup>2+</sup> during muscle contractions also contributes to pathways involved in increased glucose uptake by the muscles [<xref rid="B39-ijerph-20-06958" ref-type="bibr">39</xref>,<xref rid="B42-ijerph-20-06958" ref-type="bibr">42</xref>]. Ca<sup>2+</sup> stimulates glucose transport through the activation of CaMK, specifically CaMKII, which is the primary isoform of CaMK found in skeletal muscle [<xref rid="B43-ijerph-20-06958" ref-type="bibr">43</xref>]. Although there is evidence that CaMKII regulates glucose uptake through AMPK-dependent mechanisms [<xref rid="B44-ijerph-20-06958" ref-type="bibr">44</xref>], a growing body of evidence indicates that CaMKII-dependent signaling regulates skeletal muscle glucose uptake independent of AMPK, Akt, and AS160 phosphorylation [<xref rid="B45-ijerph-20-06958" ref-type="bibr">45</xref>,<xref rid="B46-ijerph-20-06958" ref-type="bibr">46</xref>]. In our previous work, we showed higher activation of CaMKII in response to an acute bout of NMES-RT in individuals with SCI compared with non-injured individuals, which suggests that NMES-RT was sufficient to activate CaMK-dependent pathways [<xref rid="B36-ijerph-20-06958" ref-type="bibr">36</xref>]. Our recent findings showed an increase in the total levels of CaMKII in both groups, but the increase was much higher in the Comb-NMES group (<italic toggle="yes">p</italic> &lt; 0.05, 67% vs. 16%), suggesting that GLUT-4 translocation is improved via the upregulation of CamKII.</p>
                <p>The phosphorylation of glucose by hexokinase is required for glucose uptake in skeletal muscle [<xref rid="B47-ijerph-20-06958" ref-type="bibr">47</xref>]. The phosphorylated glucose is unable to leave the cell and is the substrate for metabolism. Studies have shown that the robust translocation of GLUT4 to the cell surface in response to exercise or insulin increases permeability to glucose, increasing the contribution of hexokinase II to control muscle glucose uptake [<xref rid="B48-ijerph-20-06958" ref-type="bibr">48</xref>,<xref rid="B49-ijerph-20-06958" ref-type="bibr">49</xref>]. While membrane transport via GLUT 4 is considered a primary site for insulin resistance, glucose phosphorylation is also a significant component of muscle insulin resistance. Our findings of a 170% increase in Hexokinase II (<italic toggle="yes">p</italic> &lt; 0.05), a 49% increase in GLUT-4, and an upregulation of IRS-1 and CaMK-II suggest improved glucose transport, uptake, and phosphorylation in the paralyzed muscle in response to Comb-NMES training.</p>
              </sec>
              <sec id="sec4dot3-ijerph-20-06958">
                <title>4.3. Myofiber Type Distribution</title>
                <p>Paralyzed muscle shows a dramatic shift toward increasing IIx fibers soon after injury [<xref rid="B50-ijerph-20-06958" ref-type="bibr">50</xref>]. Electrical stimulation training increases the size [<xref rid="B8-ijerph-20-06958" ref-type="bibr">8</xref>], strength [<xref rid="B51-ijerph-20-06958" ref-type="bibr">51</xref>], and fatigue resistance [<xref rid="B52-ijerph-20-06958" ref-type="bibr">52</xref>] of paralyzed muscles, as well as inducing a type IIx to IIa fiber type conversion [<xref rid="B41-ijerph-20-06958" ref-type="bibr">41</xref>]. These adaptations plateau after around 3–6 months of training [<xref rid="B41-ijerph-20-06958" ref-type="bibr">41</xref>,<xref rid="B51-ijerph-20-06958" ref-type="bibr">51</xref>]. There is a significant gap in the literature for studies investigating adaptations in myofiber type in response to electrical stimulation after SCI. The transformation from type II to type I fibers has seldom been reported [<xref rid="B53-ijerph-20-06958" ref-type="bibr">53</xref>], even after 1 year of training [<xref rid="B54-ijerph-20-06958" ref-type="bibr">54</xref>]. However, an increase in type I mRNA has been observed after 4 weeks of intense, daily, low-frequency stimulation. One study showed that 16 weeks of isometric electrical stimulation training for 60 min, 5 times per week during the first 5 months after injury, was not sufficient to maintain type I fibers in 6 individuals with complete (AIS A) paraplegia (T5–T11) [<xref rid="B55-ijerph-20-06958" ref-type="bibr">55</xref>]. Participants showed more minor alterations in type I fibers (49% to 40%). Previously, we assessed the effects of 8 weeks of NMES-RE on VL muscle fiber type distribution in individuals with long-standing SCI. Despite the increase in type IIa fiber size, we demonstrated that type I fiber distribution was not changed following NMES-RE. We concluded that low-intensity, chronic aerobic NMES training might be needed to increase type I fiber distribution. As shown by time-series studies and the biochemistry of single fibers [<xref rid="B56-ijerph-20-06958" ref-type="bibr">56</xref>,<xref rid="B57-ijerph-20-06958" ref-type="bibr">57</xref>,<xref rid="B58-ijerph-20-06958" ref-type="bibr">58</xref>,<xref rid="B59-ijerph-20-06958" ref-type="bibr">59</xref>], when chronic, low-frequency stimulation is applied to a predominantly fast muscle, the fast muscle first changes its metabolic properties, followed by its contractile properties, until it completely transforms into a slow muscle. The present study supports these findings and shows that up to 30 min of 2–7 Hz twitch electrical stimulation per day, three times per week, included a fiber type shift from IIx to type I fibers. Therefore, early prevention via low-frequency chronic stimulation may be the key to maintaining or increasing type I fatigue-resistant and oxidative fibers after SCI. Our low-intensity aerobic NMES protocol was adapted from Ryan et al. [<xref rid="B17-ijerph-20-06958" ref-type="bibr">17</xref>] and Petrie et al. [<xref rid="B60-ijerph-20-06958" ref-type="bibr">60</xref>]. Their study showed increased mitochondrial muscle capacity and oxidative phosphorylation following a 24-week, 7 Hz, twitch electrical stimulation (pulse duration/interval = 200/50 µs) of the quadriceps muscle group. Although they did not determine the changes in myofiber type, the 3-fold increase in mitochondrial capacity was substantially more significant than that reported with traditional functional electrical stimulation (FES) exercise programs. This significant change may be due to a marked increase in type I fibers [<xref rid="B61-ijerph-20-06958" ref-type="bibr">61</xref>,<xref rid="B62-ijerph-20-06958" ref-type="bibr">62</xref>,<xref rid="B63-ijerph-20-06958" ref-type="bibr">63</xref>], as electrical activity and muscle properties are intimately interrelated.</p>
                <p>Our study has several limitations. Firstly, the small sample size (<italic toggle="yes">N</italic> = 20) may have limited our power to detect significant changes in some of the study outcome measures and further delineate the impact of covariates, such as level of injury and duration of intervention. Secondly, we did not record participants’ habitual dietary intake, and therefore we cannot determine if our interventions elicited any changes in participants’ diet behaviors and if this had an effect on metabolic response. Finally, we did not directly measure glucose transport, uptake, or utilization; therefore, we can only speculate that it is possible that the upregulation of signaling proteins resulted in improved glucose utilization in the paralyzed muscle.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec5-ijerph-20-06958">
              <title>5. Conclusions</title>
              <p>Our collective data suggest that maintaining healthy myofiber type and metabolic function may be achieved via early utilization of Comb-NMES training in individuals with SCI. Future work should aim to determine the efficacy of home-based Comb-NMES for maintaining or enhancing the metabolic improvements gained during inpatient rehabilitation.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>We sincerely thank the participants for their tireless dedication.</p>
            </ack>
            <fn-group>
              <fn>
                <p><bold>Disclaimer/Publisher’s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p>
              </fn>
            </fn-group>
            <app-group>
              <app id="app1-ijerph-20-06958">
                <title>Supplementary Materials</title>
                <p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/ijerph20206958/s1">https://www.mdpi.com/article/10.3390/ijerph20206958/s1</uri>, The uncropped, untouched, full original image of western blot presenting GLUT4, AMPK-α, p-AMPK-α Thr172, CaMKII, p-CaMKII Thr286, AKT, p-AKT Ser473, AS160, p-AS160 Thr642, Hexokinase II, IRS-1, p-IRS-1 Tyr895, Glycogen Synthase.</p>
                <supplementary-material id="ijerph-20-06958-s001" position="float" content-type="local-data">
                  <media xlink:href="ijerph-20-06958-s001.zip">
                    <caption>
                      <p>Click here for additional data file.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </app>
            </app-group>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, C.Y.-F.; methodology, C.Y.-F. and E.W.; formal analysis, J.L. and E.W.; investigation, C.Y.-F. and A.A.; writing—original draft preparation, A.A. and C.Y.-F.; writing—review and editing, C.Y.-F., J.L., E.W. and M.F.; visualization, A.A.; supervision, C.Y.-F.; project administration, C.Y.-F.; funding acquisition, C.Y.-F. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the University of Alabama at Birmingham (UAB) (IRB-170131007, 15 July 2017).</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>The study was approved by the Institutional Review Board. All participants gave written, informed consent after hearing a thorough explanation of study procedures and risks, and after having an opportunity to ask questions.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>The data that support the findings of this study are available on request from the corresponding author, [CYF].</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-ijerph-20-06958">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bauman</surname>
                      <given-names>W.A.</given-names>
                    </name>
                    <name>
                      <surname>Spungen</surname>
                      <given-names>A.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: A model of premature aging</article-title>
                  <source>Metabolism</source>
                  <year>1994</year>
                  <volume>43</volume>
                  <fpage>749</fpage>
                  <lpage>756</lpage>
                  <pub-id pub-id-type="doi">10.1016/0026-0495(94)90126-0</pub-id>
                  <?supplied-pmid 8201966?>
                  <pub-id pub-id-type="pmid">8201966</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-ijerph-20-06958">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bauman</surname>
                      <given-names>W.A.</given-names>
                    </name>
                    <name>
                      <surname>Spungen</surname>
                      <given-names>A.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Invited review carbohydrate and lipid metabolism in chronic spinal Cord Injury</article-title>
                  <source>J. Spinal Cord Med.</source>
                  <year>2001</year>
                  <volume>24</volume>
                  <fpage>266</fpage>
                  <lpage>277</lpage>
                  <pub-id pub-id-type="doi">10.1080/10790268.2001.11753584</pub-id>
                  <pub-id pub-id-type="pmid">11944785</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-ijerph-20-06958">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahuja</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Nori</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Kotter</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Druschel</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Curt</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Fehlings</surname>
                      <given-names>M.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Traumatic spinal cord injury</article-title>
                  <source>Nat. Rev. Dis. Prim.</source>
                  <year>2017</year>
                  <volume>3</volume>
                  <fpage>17078</fpage>
                  <pub-id pub-id-type="doi">10.1038/nrdp.2017.18</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-ijerph-20-06958">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Slade</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>VanHiel</surname>
                      <given-names>L.R.</given-names>
                    </name>
                    <name>
                      <surname>Warren</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Dudley</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Variable-frequency-train stimulation of skeletal muscle after spinal</article-title>
                  <source>J. Rehabil. Res. Dev.</source>
                  <year>2004</year>
                  <volume>41</volume>
                  <fpage>33</fpage>
                  <lpage>40</lpage>
                  <pub-id pub-id-type="doi">10.1682/JRRD.2004.01.0033</pub-id>
                  <pub-id pub-id-type="pmid">15273895</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-ijerph-20-06958">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zierath</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Krook</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Wallberg-Henriksson</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Insulin action in skeletal muscle from patients with NIDDM</article-title>
                  <source>Insul. Action</source>
                  <year>1998</year>
                  <volume>182</volume>
                  <fpage>153</fpage>
                  <lpage>160</lpage>
                </element-citation>
              </ref>
              <ref id="B6-ijerph-20-06958">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Castro</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Apple</surname>
                      <given-names>D.F.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Hillegass</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Dudley</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Influence of complete spinal cord injury on skeletal muscle cross-sectional area within the first 6 months of injury</article-title>
                  <source>Eur. J. Appl. Physiol. Occup. Physiol.</source>
                  <year>1999</year>
                  <volume>80</volume>
                  <fpage>373</fpage>
                  <lpage>378</lpage>
                  <pub-id pub-id-type="doi">10.1007/s004210050606</pub-id>
                  <?supplied-pmid 10483809?>
                  <pub-id pub-id-type="pmid">10483809</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-ijerph-20-06958">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Staten</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Kelley</surname>
                      <given-names>D.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Using oral challenge testing to assess insulin action and secretion with mathematical modeling</article-title>
                  <source>Diabetes</source>
                  <year>2014</year>
                  <volume>63</volume>
                  <fpage>1188</fpage>
                  <pub-id pub-id-type="doi">10.2337/db13-1839</pub-id>
                  <pub-id pub-id-type="pmid">24651802</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-ijerph-20-06958">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Yarar-Fisher</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Mahoney</surname>
                      <given-names>E.T.</given-names>
                    </name>
                    <name>
                      <surname>McCully</surname>
                      <given-names>K.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Neuromuscular electrical stimulation–induced resistance training after SCI: A review of the Dudley protocol</article-title>
                  <source>Top. Spinal Cord Inj. Rehabil.</source>
                  <year>2015</year>
                  <volume>21</volume>
                  <fpage>294</fpage>
                  <lpage>302</lpage>
                  <pub-id pub-id-type="doi">10.1310/sci2104-294</pub-id>
                  <pub-id pub-id-type="pmid">26689694</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-ijerph-20-06958">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gower</surname>
                      <given-names>B.A.</given-names>
                    </name>
                    <name>
                      <surname>Chandler-Laney</surname>
                      <given-names>P.C.</given-names>
                    </name>
                    <name>
                      <surname>Ovalle</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Goree</surname>
                      <given-names>L.L.</given-names>
                    </name>
                    <name>
                      <surname>Azziz</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Desmond</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Granger</surname>
                      <given-names>W.M.</given-names>
                    </name>
                    <name>
                      <surname>Goss</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Bates</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS</article-title>
                  <source>Clin. Endocrinol.</source>
                  <year>2013</year>
                  <volume>79</volume>
                  <fpage>550</fpage>
                  <lpage>557</lpage>
                  <pub-id pub-id-type="doi">10.1111/cen.12175</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-ijerph-20-06958">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Breda</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Cavaghan</surname>
                      <given-names>M.K.</given-names>
                    </name>
                    <name>
                      <surname>Toffolo</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Polonsky</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Cobelli</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral glucose tolerance test minimal model indexes of β-cell function and insulin sensitivity</article-title>
                  <source>Diabetes</source>
                  <year>2001</year>
                  <volume>50</volume>
                  <fpage>150</fpage>
                  <lpage>158</lpage>
                  <pub-id pub-id-type="doi">10.2337/diabetes.50.1.150</pub-id>
                  <pub-id pub-id-type="pmid">11147781</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-ijerph-20-06958">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCully</surname>
                      <given-names>K.K.</given-names>
                    </name>
                    <name>
                      <surname>Mulcahy</surname>
                      <given-names>T.K.</given-names>
                    </name>
                    <name>
                      <surname>Ryan</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>Q.</given-names>
                    </name>
                  </person-group>
                  <article-title>Skeletal muscle metabolism in individuals with spinal cord injury</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2011</year>
                  <volume>111</volume>
                  <fpage>143</fpage>
                  <lpage>148</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00094.2011</pub-id>
                  <pub-id pub-id-type="pmid">21512153</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-ijerph-20-06958">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gorgey</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Shepherd</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Skeletal muscle hypertrophy and decreased intramuscular fat after unilateral resistance training in spinal cord injury: Case report</article-title>
                  <source>J. Spinal Cord Med.</source>
                  <year>2010</year>
                  <volume>33</volume>
                  <fpage>90</fpage>
                  <lpage>95</lpage>
                  <pub-id pub-id-type="doi">10.1080/10790268.2010.11689681</pub-id>
                  <pub-id pub-id-type="pmid">20397451</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-ijerph-20-06958">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yarar-Fisher</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Polston</surname>
                      <given-names>K.F.</given-names>
                    </name>
                    <name>
                      <surname>Eraslan</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Henley</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Polston</surname>
                      <given-names>K.F.</given-names>
                    </name>
                    <name>
                      <surname>Eraslan</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Henley</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Kinikli</surname>
                      <given-names>G.I.</given-names>
                    </name>
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Windham</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Paralytic and nonparalytic muscle adaptations to exercise training versus high-protein diet in individuals with long-standing spinal cord injury</article-title>
                  <source>J. App. Phys.</source>
                  <year>2018</year>
                  <volume>125</volume>
                  <fpage>64</fpage>
                  <lpage>72</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.01029.2017</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-ijerph-20-06958">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dudley</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Castro</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rogers</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Apple</surname>
                      <given-names>D.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                  </person-group>
                  <article-title>A simple means of increasing muscle size after spinal cord injury: A pilot study</article-title>
                  <source>Eur. J. Appl. Physiol. Occup. Physiol.</source>
                  <year>1999</year>
                  <volume>80</volume>
                  <fpage>394</fpage>
                  <lpage>396</lpage>
                  <pub-id pub-id-type="doi">10.1007/s004210050609</pub-id>
                  <pub-id pub-id-type="pmid">10483812</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-ijerph-20-06958">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ryan</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Brizendine</surname>
                      <given-names>J.T.</given-names>
                    </name>
                    <name>
                      <surname>Backus</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>McCully</surname>
                      <given-names>K.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Electrically induced resistance training in individuals with motor complete spinal cord injury</article-title>
                  <source>Arch. Phys. Med. Rehabil.</source>
                  <year>2013</year>
                  <volume>94</volume>
                  <fpage>2166</fpage>
                  <lpage>2173</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.apmr.2013.06.016</pub-id>
                  <pub-id pub-id-type="pmid">23816921</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-ijerph-20-06958">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mahoney</surname>
                      <given-names>E.T.</given-names>
                    </name>
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Elder</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Slade</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Apple</surname>
                      <given-names>D.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Dudley</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in skeletal muscle size and glucose tolerance with electrically stimulated resistance training in subjects with chronic spinal cord injury</article-title>
                  <source>Arch. Phys. Med. Rehabil.</source>
                  <year>2005</year>
                  <volume>86</volume>
                  <fpage>1502</fpage>
                  <lpage>1504</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.apmr.2004.12.021</pub-id>
                  <pub-id pub-id-type="pmid">16003691</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-ijerph-20-06958">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ryan</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Erickson</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>H.-J.</given-names>
                    </name>
                    <name>
                      <surname>McCully</surname>
                      <given-names>K.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Case report: Endurance electrical stimulation training improves skeletal muscle oxidative capacity in chronic spinal cord injury</article-title>
                  <source>Arch. Phys. Med. Rehabil.</source>
                  <year>2013</year>
                  <volume>94</volume>
                  <fpage>2559</fpage>
                  <lpage>2561</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.apmr.2013.06.014</pub-id>
                  <pub-id pub-id-type="pmid">23816924</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-ijerph-20-06958">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bamman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                    <name>
                      <surname>Ragan</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.-S.</given-names>
                    </name>
                    <name>
                      <surname>Cross</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Hill</surname>
                      <given-names>V.J.</given-names>
                    </name>
                    <name>
                      <surname>Tuggle</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Allman</surname>
                      <given-names>R.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Myogenic protein expression before and after resistance loading in 26-and 64-yr-old men and women</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2004</year>
                  <volume>97</volume>
                  <fpage>1329</fpage>
                  <lpage>1337</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.01387.2003</pub-id>
                  <?supplied-pmid 15155718?>
                  <pub-id pub-id-type="pmid">15155718</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-ijerph-20-06958">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Merritt</surname>
                      <given-names>E.K.</given-names>
                    </name>
                    <name>
                      <surname>Stec</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Thalacker-Mercer</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Windham</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Cross</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Shelley</surname>
                      <given-names>D.P.</given-names>
                    </name>
                    <name>
                      <surname>Tuggle</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Kosek</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.-S.</given-names>
                    </name>
                    <name>
                      <surname>Bamman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2013</year>
                  <volume>115</volume>
                  <fpage>937</fpage>
                  <lpage>948</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00019.2013</pub-id>
                  <?supplied-pmid 23681911?>
                  <pub-id pub-id-type="pmid">23681911</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-ijerph-20-06958">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kelly</surname>
                      <given-names>N.A.</given-names>
                    </name>
                    <name>
                      <surname>Ford</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Standaert</surname>
                      <given-names>D.G.</given-names>
                    </name>
                    <name>
                      <surname>Watts</surname>
                      <given-names>R.L.</given-names>
                    </name>
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Moellering</surname>
                      <given-names>D.R.</given-names>
                    </name>
                    <name>
                      <surname>Tuggle</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                    <name>
                      <surname>Lieb</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Windham</surname>
                      <given-names>S.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson’s disease</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2014</year>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.01277.2013</pub-id>
                  <?supplied-pmid 24408997?>
                  <pub-id pub-id-type="pmid">24408997</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-ijerph-20-06958">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mayhew</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Hornberger</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Lincoln</surname>
                      <given-names>H.C.</given-names>
                    </name>
                    <name>
                      <surname>Bamman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Eukaryotic initiation factor 2B epsilon induces cap-dependent translation and skeletal muscle hypertrophy</article-title>
                  <source>J. Physiol.</source>
                  <year>2011</year>
                  <volume>589</volume>
                  <fpage>3023</fpage>
                  <lpage>3037</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.2010.202432</pub-id>
                  <pub-id pub-id-type="pmid">21486778</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-ijerph-20-06958">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thalacker-Mercer</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Dell</surname>
                      <given-names>L.J.</given-names>
                    </name>
                    <name>
                      <surname>Cui</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Cross</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Bamman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Differential genomic responses in old vs. young humans despite similar levels of modest muscle damage after resistance loading</article-title>
                  <source>Physiol. Genom.</source>
                  <year>2010</year>
                  <volume>40</volume>
                  <fpage>141</fpage>
                  <lpage>149</lpage>
                  <pub-id pub-id-type="doi">10.1152/physiolgenomics.00151.2009</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-ijerph-20-06958">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Knopfholz</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Disserol</surname>
                      <given-names>C.C.D.</given-names>
                    </name>
                    <name>
                      <surname>Pierin</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Schirr</surname>
                      <given-names>F.L.</given-names>
                    </name>
                    <name>
                      <surname>Streisky</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Takito</surname>
                      <given-names>L.L.</given-names>
                    </name>
                    <name>
                      <surname>Ledesma</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Faria-Neto</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Olandoski</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Da Cunha</surname>
                      <given-names>C.L.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Validation of the friedewald formula in patients with metabolic syndrome</article-title>
                  <source>Cholesterol</source>
                  <year>2014</year>
                  <volume>2014</volume>
                  <fpage>261878</fpage>
                  <pub-id pub-id-type="doi">10.1155/2014/261878</pub-id>
                  <?supplied-pmid 24672715?>
                  <pub-id pub-id-type="pmid">24672715</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-ijerph-20-06958">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Polston</surname>
                      <given-names>K.F.L.</given-names>
                    </name>
                    <name>
                      <surname>Eraslan</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Windham</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>McLain</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Oster</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Bamman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                    <name>
                      <surname>Yarar-Fisher</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>A high-protein diet or combination exercise training to improve metabolic health in individuals with long-standing spinal cord injury: A pilot randomized study</article-title>
                  <source>Physiol. Rep.</source>
                  <year>2018</year>
                  <volume>6</volume>
                  <fpage>e13813</fpage>
                  <pub-id pub-id-type="doi">10.14814/phy2.13813</pub-id>
                  <?supplied-pmid 30156033?>
                  <pub-id pub-id-type="pmid">30156033</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-ijerph-20-06958">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stuart</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>McCurry</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Marino</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>South</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Howell</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Layne</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Ramsey</surname>
                      <given-names>M.W.</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>M.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2013</year>
                  <volume>98</volume>
                  <fpage>2027</fpage>
                  <lpage>2036</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2012-3876</pub-id>
                  <?supplied-pmid 23515448?>
                  <pub-id pub-id-type="pmid">23515448</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-ijerph-20-06958">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zierath</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Guma</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Wahlström</surname>
                      <given-names>E.O.</given-names>
                    </name>
                    <name>
                      <surname>Klip</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Wallberg-Henriksson</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM</article-title>
                  <source>Diabetologia</source>
                  <year>1996</year>
                  <volume>39</volume>
                  <fpage>1180</fpage>
                  <lpage>1189</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF02658504</pub-id>
                  <?supplied-pmid 8897005?>
                  <pub-id pub-id-type="pmid">8897005</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-ijerph-20-06958">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gaster</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Staehr</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Beck-Nielsen</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Schrøder</surname>
                      <given-names>H.D.</given-names>
                    </name>
                    <name>
                      <surname>Handberg</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: Is insulin resistance in type 2 diabetes a slow, type 1 fiber disease?</article-title>
                  <source>Diabetes</source>
                  <year>2001</year>
                  <volume>50</volume>
                  <fpage>1324</fpage>
                  <lpage>1329</lpage>
                  <pub-id pub-id-type="doi">10.2337/diabetes.50.6.1324</pub-id>
                  <?supplied-pmid 11375332?>
                  <pub-id pub-id-type="pmid">11375332</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-ijerph-20-06958">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Daugaard</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Nielsen</surname>
                      <given-names>J.N.</given-names>
                    </name>
                    <name>
                      <surname>Kristiansen</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Andersen</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Hargreaves</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Richter</surname>
                      <given-names>E.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Fiber type-specific expression of GLUT4 in human skeletal muscle: Influence of exercise training</article-title>
                  <source>Diabetes</source>
                  <year>2000</year>
                  <volume>49</volume>
                  <fpage>1092</fpage>
                  <lpage>1095</lpage>
                  <pub-id pub-id-type="doi">10.2337/diabetes.49.7.1092</pub-id>
                  <pub-id pub-id-type="pmid">10909963</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-ijerph-20-06958">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Silverman</surname>
                      <given-names>M.G.</given-names>
                    </name>
                    <name>
                      <surname>Ference</surname>
                      <given-names>B.A.</given-names>
                    </name>
                    <name>
                      <surname>Im</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Wiviott</surname>
                      <given-names>S.D.</given-names>
                    </name>
                    <name>
                      <surname>Giugliano</surname>
                      <given-names>R.P.</given-names>
                    </name>
                    <name>
                      <surname>Grundy</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Braunwald</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Sabatine</surname>
                      <given-names>M.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis</article-title>
                  <source>JAMA</source>
                  <year>2016</year>
                  <volume>316</volume>
                  <fpage>1289</fpage>
                  <lpage>1297</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2016.13985</pub-id>
                  <pub-id pub-id-type="pmid">27673306</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-ijerph-20-06958">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holmes</surname>
                      <given-names>M.V.</given-names>
                    </name>
                    <name>
                      <surname>Ala-Korpela</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>What is ‘LDL cholesterol’?</article-title>
                  <source>Nat. Rev. Cardiol.</source>
                  <year>2019</year>
                  <volume>16</volume>
                  <fpage>197</fpage>
                  <lpage>198</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41569-019-0157-6</pub-id>
                  <pub-id pub-id-type="pmid">30700860</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-ijerph-20-06958">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bochkezanian</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Newton</surname>
                      <given-names>R.U.</given-names>
                    </name>
                    <name>
                      <surname>Trajano</surname>
                      <given-names>G.S.</given-names>
                    </name>
                    <name>
                      <surname>Blazevich</surname>
                      <given-names>A.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of neuromuscular electrical stimulation in people with spinal cord injury</article-title>
                  <source>Med. Sci. Sports Exerc.</source>
                  <year>2018</year>
                  <volume>50</volume>
                  <fpage>1733</fpage>
                  <lpage>1739</lpage>
                  <pub-id pub-id-type="doi">10.1249/MSS.0000000000001637</pub-id>
                  <pub-id pub-id-type="pmid">29634640</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-ijerph-20-06958">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gorgey</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Khalil</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Gill</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Khan</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Adler</surname>
                      <given-names>R.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of dose de-escalation following testosterone treatment and evoked resistance exercise on body composition, metabolic profile, and neuromuscular parameters in persons with spinal cord injury</article-title>
                  <source>Physiol. Rep.</source>
                  <year>2021</year>
                  <volume>9</volume>
                  <fpage>e15089</fpage>
                  <pub-id pub-id-type="doi">10.14814/phy2.15089</pub-id>
                  <pub-id pub-id-type="pmid">34713983</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-ijerph-20-06958">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Erickson</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Ryan</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Backus</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>McCully</surname>
                      <given-names>K.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Endurance neuromuscular electrical stimulation training improves skeletal muscle oxidative capacity in individuals with motor-complete spinal cord injury</article-title>
                  <source>Muscle Nerve</source>
                  <year>2017</year>
                  <volume>55</volume>
                  <fpage>669</fpage>
                  <lpage>675</lpage>
                  <pub-id pub-id-type="doi">10.1002/mus.25393</pub-id>
                  <pub-id pub-id-type="pmid">27576602</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-ijerph-20-06958">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jessen</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Goodyear</surname>
                      <given-names>L.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Contraction signaling to glucose transport in skeletal muscle</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2005</year>
                  <volume>99</volume>
                  <fpage>330</fpage>
                  <lpage>337</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00175.2005</pub-id>
                  <?supplied-pmid 16036906?>
                  <pub-id pub-id-type="pmid">16036906</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-ijerph-20-06958">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holloszy</surname>
                      <given-names>J.O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exercise-induced increase in muscle insulin sensitivity</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2005</year>
                  <volume>99</volume>
                  <fpage>338</fpage>
                  <lpage>343</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00123.2005</pub-id>
                  <?supplied-pmid 16036907?>
                  <pub-id pub-id-type="pmid">16036907</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-ijerph-20-06958">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yarar-Fisher</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Windham</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>McLain</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Bamman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Skeletal muscle signaling associated with impaired glucose tolerance in spinal cord-injured men and the effects of contractile activity</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2013</year>
                  <volume>115</volume>
                  <fpage>756</fpage>
                  <lpage>764</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00122.2013</pub-id>
                  <?supplied-pmid 23766505?>
                  <pub-id pub-id-type="pmid">23766505</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-ijerph-20-06958">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ryder</surname>
                      <given-names>J.W.</given-names>
                    </name>
                    <name>
                      <surname>Chibalin</surname>
                      <given-names>A.V.</given-names>
                    </name>
                    <name>
                      <surname>Zierath</surname>
                      <given-names>J.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle</article-title>
                  <source>Acta Physiol. Scand.</source>
                  <year>2001</year>
                  <volume>171</volume>
                  <fpage>249</fpage>
                  <lpage>257</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1365-201x.2001.00827.x</pub-id>
                  <?supplied-pmid 11412137?>
                  <pub-id pub-id-type="pmid">11412137</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-ijerph-20-06958">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Winder</surname>
                      <given-names>W.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2001</year>
                  <volume>91</volume>
                  <fpage>1017</fpage>
                  <lpage>1028</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.2001.91.3.1017</pub-id>
                  <?supplied-pmid 11509493?>
                  <pub-id pub-id-type="pmid">11509493</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-ijerph-20-06958">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Murgia</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Jensen</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Cusinato</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Garcia</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Richter</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Schiaffino</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle</article-title>
                  <source>J. Physiol.</source>
                  <year>2009</year>
                  <volume>587</volume>
                  <issue-part>Pt 17</issue-part>
                  <fpage>4319</fpage>
                  <lpage>4327</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.2009.174888</pub-id>
                  <?supplied-pmid 19596898?>
                  <pub-id pub-id-type="pmid">19596898</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-ijerph-20-06958">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cartee</surname>
                      <given-names>G.D.</given-names>
                    </name>
                    <name>
                      <surname>Wojtaszewski</surname>
                      <given-names>J.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport</article-title>
                  <source>Appl. Physiol. Nutr. Metab.</source>
                  <year>2007</year>
                  <volume>32</volume>
                  <fpage>557</fpage>
                  <lpage>566</lpage>
                  <pub-id pub-id-type="doi">10.1139/H07-026</pub-id>
                  <pub-id pub-id-type="pmid">17510697</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-ijerph-20-06958">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mohr</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Andersen</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Biering-Sørensen</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Galbo</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Bangsbo</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wagner</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kjaer</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Long term adaptation to electrically induced cycle training in severe spinal cord injured individuals</article-title>
                  <source>Spinal Cord.</source>
                  <year>1997</year>
                  <volume>35</volume>
                  <fpage>1</fpage>
                  <lpage>16</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.sc.3100343</pub-id>
                  <pub-id pub-id-type="pmid">9025213</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-ijerph-20-06958">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ojuka</surname>
                      <given-names>E.O.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Nolte</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Wamhoff</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Sturek</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Holloszy</surname>
                      <given-names>J.O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation of GLUT4 biogenesis in muscle: Evidence for involvement of AMPK and Ca(<sup>2+</sup>)</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2002</year>
                  <volume>282</volume>
                  <fpage>E1008</fpage>
                  <lpage>E1013</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00512.2001</pub-id>
                  <?supplied-pmid 11934664?>
                  <pub-id pub-id-type="pmid">11934664</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-ijerph-20-06958">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rose</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Kiens</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Richter</surname>
                      <given-names>E.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ca<sup>2+</sup>-calmodulin-dependent protein kinase expression and signalling in skeletal muscle during exercise</article-title>
                  <source>J. Physiol.</source>
                  <year>2006</year>
                  <volume>574</volume>
                  <issue-part>Pt 3</issue-part>
                  <fpage>889</fpage>
                  <lpage>903</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.2006.111757</pub-id>
                  <?supplied-pmid 16690701?>
                  <pub-id pub-id-type="pmid">16690701</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-ijerph-20-06958">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jensen</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Rose</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Hellsten</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Wojtaszewski</surname>
                      <given-names>J.F.</given-names>
                    </name>
                    <name>
                      <surname>Richter</surname>
                      <given-names>E.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Caffeine-induced Ca(<sup>2+</sup>) release increases AMPK-dependent glucose uptake in rodent soleus muscle</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2007</year>
                  <volume>293</volume>
                  <fpage>E286</fpage>
                  <lpage>E292</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00693.2006</pub-id>
                  <?supplied-pmid 17405829?>
                  <pub-id pub-id-type="pmid">17405829</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-ijerph-20-06958">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Witczak</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Fujii</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Hirshman</surname>
                      <given-names>M.F.</given-names>
                    </name>
                    <name>
                      <surname>Goodyear</surname>
                      <given-names>L.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ca<sup>2+</sup>/calmodulin-dependent protein kinase kinase-alpha regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation</article-title>
                  <source>Diabetes</source>
                  <year>2007</year>
                  <volume>56</volume>
                  <fpage>1403</fpage>
                  <lpage>1409</lpage>
                  <pub-id pub-id-type="doi">10.2337/db06-1230</pub-id>
                  <?supplied-pmid 17287469?>
                  <pub-id pub-id-type="pmid">17287469</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-ijerph-20-06958">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Witczak</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Jessen</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Warro</surname>
                      <given-names>D.M.</given-names>
                    </name>
                    <name>
                      <surname>Toyoda</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Fujii</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Hirshman</surname>
                      <given-names>M.F.</given-names>
                    </name>
                    <name>
                      <surname>Goodyear</surname>
                      <given-names>L.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2010</year>
                  <volume>298</volume>
                  <fpage>E1150</fpage>
                  <lpage>E1160</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00659.2009</pub-id>
                  <?supplied-pmid 20215576?>
                  <pub-id pub-id-type="pmid">20215576</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-ijerph-20-06958">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wasserman</surname>
                      <given-names>D.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Insulin, Muscle Glucose Uptake, and Hexokinase: Revisiting the Road Not Taken</article-title>
                  <source>Physiology</source>
                  <year>2022</year>
                  <volume>37</volume>
                  <fpage>115</fpage>
                  <lpage>127</lpage>
                  <pub-id pub-id-type="doi">10.1152/physiol.00034.2021</pub-id>
                  <?supplied-pmid 34779282?>
                  <pub-id pub-id-type="pmid">34779282</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-ijerph-20-06958">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>P.Y.</given-names>
                    </name>
                    <name>
                      <surname>Jensen</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Printz</surname>
                      <given-names>R.L.</given-names>
                    </name>
                    <name>
                      <surname>Granner</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Ivy</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Moller</surname>
                      <given-names>D.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>1996</year>
                  <volume>271</volume>
                  <fpage>14834</fpage>
                  <lpage>14839</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.271.25.14834</pub-id>
                  <pub-id pub-id-type="pmid">8662926</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-ijerph-20-06958">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fueger</surname>
                      <given-names>P.T.</given-names>
                    </name>
                    <name>
                      <surname>Lee-Young</surname>
                      <given-names>R.S.</given-names>
                    </name>
                    <name>
                      <surname>Shearer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bracy</surname>
                      <given-names>D.P.</given-names>
                    </name>
                    <name>
                      <surname>Heikkinen</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Laakso</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rottman</surname>
                      <given-names>J.N.</given-names>
                    </name>
                    <name>
                      <surname>Wasserman</surname>
                      <given-names>D.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: Studies in mice with a 50% reduction of hexokinase II</article-title>
                  <source>Diabetes</source>
                  <year>2007</year>
                  <volume>56</volume>
                  <fpage>2476</fpage>
                  <lpage>2484</lpage>
                  <pub-id pub-id-type="doi">10.2337/db07-0532</pub-id>
                  <pub-id pub-id-type="pmid">17639019</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-ijerph-20-06958">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yarar-Fisher</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bickel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Kelly</surname>
                      <given-names>N.A.</given-names>
                    </name>
                    <name>
                      <surname>Stec</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Windham</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>McLain</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Oster</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Bamman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2016</year>
                  <volume>310</volume>
                  <fpage>E754</fpage>
                  <lpage>E761</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00240.2015</pub-id>
                  <pub-id pub-id-type="pmid">26931128</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-ijerph-20-06958">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duffell</surname>
                      <given-names>L.D.</given-names>
                    </name>
                    <name>
                      <surname>Donaldson</surname>
                      <given-names>N.D.N.</given-names>
                    </name>
                    <name>
                      <surname>Perkins</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Rushton</surname>
                      <given-names>D.N.</given-names>
                    </name>
                    <name>
                      <surname>Hunt</surname>
                      <given-names>K.J.</given-names>
                    </name>
                    <name>
                      <surname>Kakebeeke</surname>
                      <given-names>T.H.</given-names>
                    </name>
                    <name>
                      <surname>Newham</surname>
                      <given-names>D.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Long-term intensive electrically stimulated cycling by spinal cord–injured people: Effect on muscle properties and their relation to power output</article-title>
                  <source>Muscle Nerve Off. J. Am. Assoc. Electrodiagn. Med.</source>
                  <year>2008</year>
                  <volume>38</volume>
                  <fpage>1304</fpage>
                  <lpage>1311</lpage>
                </element-citation>
              </ref>
              <ref id="B52-ijerph-20-06958">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gerrits</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Hopman</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Sargeant</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>De Haan</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of training on contractile properties of paralyzed quadriceps muscle</article-title>
                  <source>Muscle Nerve</source>
                  <year>2002</year>
                  <volume>25</volume>
                  <fpage>559</fpage>
                  <lpage>567</lpage>
                  <pub-id pub-id-type="doi">10.1002/mus.10071</pub-id>
                  <pub-id pub-id-type="pmid">11932974</pub-id>
                </element-citation>
              </ref>
              <ref id="B53-ijerph-20-06958">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Martin</surname>
                      <given-names>T.P.</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Hoeppner</surname>
                      <given-names>P.H.</given-names>
                    </name>
                    <name>
                      <surname>Reid</surname>
                      <given-names>D.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Influence of electrical stimulation on the morphological and metabolic properties of paralyzed muscle</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>1992</year>
                  <volume>72</volume>
                  <fpage>1401</fpage>
                  <lpage>1406</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.1992.72.4.1401</pub-id>
                  <?supplied-pmid 1534322?>
                  <pub-id pub-id-type="pmid">1534322</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-ijerph-20-06958">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Andersen</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Mohr</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Biering-Sorensen</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Galbo</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Kjaer</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Myosin heavy chain isoform transformation in single fibres from m. vastus lateralis in spinal cord injured individuals: Effects of long-term functional electrical stimulation (FES)</article-title>
                  <source>Pflug. Arch.</source>
                  <year>1996</year>
                  <volume>431</volume>
                  <fpage>513</fpage>
                  <lpage>518</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF02191897</pub-id>
                </element-citation>
              </ref>
              <ref id="B55-ijerph-20-06958">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Crameri</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Weston</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Rutkowski</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Middleton</surname>
                      <given-names>J.W.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>G.M.</given-names>
                    </name>
                    <name>
                      <surname>Sutton</surname>
                      <given-names>J.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of electrical stimulation leg training during the acute phase of spinal cord injury: A pilot study</article-title>
                  <source>Eur. J. Appl. Physiol.</source>
                  <year>2000</year>
                  <volume>83</volume>
                  <fpage>409</fpage>
                  <lpage>415</lpage>
                  <pub-id pub-id-type="doi">10.1007/s004210000263</pub-id>
                  <pub-id pub-id-type="pmid">11138583</pub-id>
                </element-citation>
              </ref>
              <ref id="B56-ijerph-20-06958">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salmons</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sreter</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Significance of impulse activity in the transformation of skeletal muscle type</article-title>
                  <source>Nature</source>
                  <year>1976</year>
                  <volume>263</volume>
                  <fpage>30</fpage>
                  <lpage>34</lpage>
                  <pub-id pub-id-type="doi">10.1038/263030a0</pub-id>
                  <?supplied-pmid 958462?>
                  <pub-id pub-id-type="pmid">958462</pub-id>
                </element-citation>
              </ref>
              <ref id="B57-ijerph-20-06958">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nix</surname>
                      <given-names>W.A.</given-names>
                    </name>
                    <name>
                      <surname>Reichmann</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Schröder</surname>
                      <given-names>M.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Influence of direct low frequency stimulation on contractile properties of denervated fast-twitch rabbit muscle</article-title>
                  <source>Pflüg. Archiv.</source>
                  <year>1985</year>
                  <volume>405</volume>
                  <fpage>141</fpage>
                  <lpage>147</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF00584535</pub-id>
                  <?supplied-pmid 4059036?>
                  <pub-id pub-id-type="pmid">4059036</pub-id>
                </element-citation>
              </ref>
              <ref id="B58-ijerph-20-06958">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salmons</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Adaptive change in electrically stimulated muscle: A framework for the design of clinical protocols</article-title>
                  <source>Muscle Nerve Off. J. Am. Assoc. Electrodiagn. Med.</source>
                  <year>2009</year>
                  <volume>40</volume>
                  <fpage>918</fpage>
                  <lpage>935</lpage>
                  <pub-id pub-id-type="doi">10.1002/mus.21497</pub-id>
                </element-citation>
              </ref>
              <ref id="B59-ijerph-20-06958">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lopez-Guajardo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sutherland</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Jarvis</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Salmons</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Induction of a fatigue-resistant phenotype in rabbit fast muscle by small daily amounts of stimulation</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2001</year>
                  <volume>90</volume>
                  <fpage>1909</fpage>
                  <lpage>1918</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.2001.90.5.1909</pub-id>
                  <pub-id pub-id-type="pmid">11299285</pub-id>
                </element-citation>
              </ref>
              <ref id="B60-ijerph-20-06958">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Petrie</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Suneja</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Shields</surname>
                      <given-names>R.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Low-frequency stimulation regulates metabolic gene expression in paralyzed muscle</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2015</year>
                  <volume>118</volume>
                  <fpage>723</fpage>
                  <lpage>731</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00628.2014</pub-id>
                  <pub-id pub-id-type="pmid">25635001</pub-id>
                </element-citation>
              </ref>
              <ref id="B61-ijerph-20-06958">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chilibeck</surname>
                      <given-names>P.D.</given-names>
                    </name>
                    <name>
                      <surname>Bell</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Jeon</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Weiss</surname>
                      <given-names>C.B.</given-names>
                    </name>
                    <name>
                      <surname>Murdoch</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>MacLean</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Ryan</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Burnham</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Functional electrical stimulation exercise increases GLUT-1 and GLUT-4 in paralyzed skeletal muscle</article-title>
                  <source>Metabolism</source>
                  <year>1999</year>
                  <volume>48</volume>
                  <fpage>1409</fpage>
                  <lpage>1413</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0026-0495(99)90151-8</pub-id>
                  <?supplied-pmid 10582549?>
                  <pub-id pub-id-type="pmid">10582549</pub-id>
                </element-citation>
              </ref>
              <ref id="B62-ijerph-20-06958">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Crameri</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Weston</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Climstein</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>G.M.</given-names>
                    </name>
                    <name>
                      <surname>Sutton</surname>
                      <given-names>J.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of electrical stimulation-induced leg training on skeletal muscle adaptability in spinal cord injury</article-title>
                  <source>Scand J. Med. Sci. Sports</source>
                  <year>2002</year>
                  <volume>12</volume>
                  <fpage>316</fpage>
                  <lpage>322</lpage>
                  <pub-id pub-id-type="doi">10.1034/j.1600-0838.2002.20106.x</pub-id>
                  <?supplied-pmid 12383078?>
                  <pub-id pub-id-type="pmid">12383078</pub-id>
                </element-citation>
              </ref>
              <ref id="B63-ijerph-20-06958">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rochester</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Barron</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Chandler</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Sutton</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>M.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Influence of electrical stimulation of the tibialis anterior muscle in paraplegic subjects. 2. Morphological and histochemical properties</article-title>
                  <source>Paraplegia</source>
                  <year>1995</year>
                  <volume>33</volume>
                  <fpage>514</fpage>
                  <lpage>522</lpage>
                  <pub-id pub-id-type="doi">10.1038/sc.1995.112</pub-id>
                  <?supplied-pmid 8524604?>
                  <pub-id pub-id-type="pmid">8524604</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="ijerph-20-06958-f001">
              <label>Figure 1</label>
              <caption>
                <p>An example of a typical training program for a participant with motor complete SCI. (<bold>A</bold>) Dudley training: Each session included four sets of 10 actions. The participant completed 4 × 10 repetitions in the first two sessions with no added weight. The weights were progressively increased by 1 lb. after achieving 40 repetitions of full knee extension in a session. The participant was able to lift 5 lbs. after 12 sessions. (<bold>B</bold>) Twitch training: The training started with 10 min of twitch stimulation at 2 Hz. After the first week, the duration of the session was progressively increased to 30 min at 7 Hz.</p>
              </caption>
              <graphic xlink:href="ijerph-20-06958-g001" position="float"/>
            </fig>
            <fig position="float" id="ijerph-20-06958-f002">
              <label>Figure 2</label>
              <caption>
                <p>Changes in glucose level (mg/dL) (<bold>A</bold>) and insulin concentrations (IU/mL) (<bold>B</bold>) in response to the interventions in the Comb-NMES and control groups at fasting. Changes within a group refer to the differences between pre- and post-training among individuals in the same group. * Statistically significant changes within the Comb-NMES group. Data are means ± SD.</p>
              </caption>
              <graphic xlink:href="ijerph-20-06958-g002" position="float"/>
            </fig>
            <fig position="float" id="ijerph-20-06958-f003">
              <label>Figure 3</label>
              <caption>
                <p>Lipid and lipoprotein levels in Comb-NMES and control at Baseline and Post-intervention. (<bold>A</bold>) cholesterol, (<bold>B</bold>) triacylglycerol, (<bold>C</bold>) high-density lipoprotein HDL, and (<bold>D</bold>) low-density lipoprotein LDL. Changes within a group refer to the differences between pre−and post−training among individuals in the same group. * Statistically significant changes within the Comb-NMES group. Data are means ± SD.</p>
              </caption>
              <graphic xlink:href="ijerph-20-06958-g003a" position="float"/>
              <graphic xlink:href="ijerph-20-06958-g003b" position="float"/>
            </fig>
            <fig position="float" id="ijerph-20-06958-f004">
              <label>Figure 4</label>
              <caption>
                <p>Normalized total (<bold>A</bold>,<bold>C</bold>,<bold>E</bold>,<bold>G</bold>,<bold>H</bold>,<bold>I</bold>,<bold>K</bold>,<bold>M</bold>) and phosphorylated (<bold>B</bold>,<bold>D</bold>,<bold>F</bold>,<bold>J</bold>,<bold>L</bold>,<bold>N</bold>) protein levels for contraction−induced glucose transporter 4 (GLUT−4) translocation signaling pathway in response to Comb-NMES or control. Changes within a group refer to the differences between pre−and posttraining among individuals in the same group. # Statistically significant changes within the group. Data are means ± SD.; Glycogen synthase, GS; Ca + 2/calmodulin-dependent protein kinase, (CaMK) II; protein kinase B, Akt; Insulin receptor substrate 1, IRS-1; AMP-activated protein kinase, AMPK; Akt substrate of kDa, Rab GTPase-activating protein), AS160.</p>
              </caption>
              <graphic xlink:href="ijerph-20-06958-g004a" position="float"/>
              <graphic xlink:href="ijerph-20-06958-g004b" position="float"/>
              <graphic xlink:href="ijerph-20-06958-g004c" position="float"/>
            </fig>
            <fig position="float" id="ijerph-20-06958-f005">
              <label>Figure 5</label>
              <caption>
                <p>Representative immunoblots for 13 studied proteins in vastus lateralis (VL) muscle samples in the Comb-NMES (<italic toggle="yes">N</italic> = 5) versus control (<italic toggle="yes">N</italic> = 3) group. The samples were loaded in the order shown.</p>
              </caption>
              <graphic xlink:href="ijerph-20-06958-g005" position="float"/>
            </fig>
            <fig position="float" id="ijerph-20-06958-f006">
              <label>Figure 6</label>
              <caption>
                <p>Representative fluorescent immunohistochemistry images from vastus lateralis (VL) muscle samples pre- and post-intervention in (<bold>A</bold>) control and (<bold>B</bold>) Comb-NMES groups. The red arrow indicates type I, the green arrow indicates type IIa, and the blue arrow indicates type IIx. (<bold>C</bold>) Muscle fiber type distribution in response to Comb-NMES and control intervention. Data are means ± SD.</p>
              </caption>
              <graphic xlink:href="ijerph-20-06958-g006" position="float"/>
            </fig>
            <table-wrap position="float" id="ijerph-20-06958-t001">
              <object-id pub-id-type="pii">ijerph-20-06958-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Baseline participant characteristics.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Participants</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gender</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Race</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AIS</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LOI</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Completeness</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Injury Type</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Days in Intervention</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Control</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">29</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">F</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T2</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">10</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 4</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">20</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">11</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 10</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">31</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">B</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">incomplete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">20</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 16</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">L1</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">24</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 19</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">21</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">F</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">16</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 20</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">20</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">FALL</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 28</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">28</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C6</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">36</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 31</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">26</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T2</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">36</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Summary statistics *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">25 ± 4.28 *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">18 (10.5–30) *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Comb-NMES</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 1</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">22</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">17</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 2</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">25</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">B</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T6</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">incomplete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">15</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 6</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">42</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">B</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C4</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">incomplete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">FALL</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">20</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 11</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">43</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">F</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C6</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">23</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 12</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">27</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">HISPANIC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">21</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 17</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">51</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">incomplete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">39</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 22</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">41</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C4</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">21</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 24</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">45</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MCC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">28</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 29</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">32</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">23</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 30</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">34</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">21</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 32</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">32</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">WHITE</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">B</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C4</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">incomplete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MVC</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">24</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SCI 33</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">24</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">M</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BLACK</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">A</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">T3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">complete</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GSW</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">17</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Summary statistics *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.8 ± 9.4 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (18.5–23.5) *</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>SCI, spinal cord injury; AIS, American Spinal Injury Association Impairment Scale; C, cervical SCI; T, thoracic SCI; LOI, level of injury; GSW, gunshot wound; MVC, motor vehicle collision; MCC, Motorcycle crash. * mean ± SD of age and median (interquartile-IQR) of days in the intervention.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="ijerph-20-06958-t002">
              <object-id pub-id-type="pii">ijerph-20-06958-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>List of antibodies used in fluorescent immunohistochemistry and immunoblotting.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antibody</th>
                    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type</th>
                    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Catalog Number</th>
                    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vendor</th>
                    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dilution</th>
                    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Host</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MHC I (slow)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">NCL-MHCs</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Leica</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:50 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Alexa 594</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Secondary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">A-11012</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ThermoFisher Scientific</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:200 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Goat</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Anti-Laminin</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">L8271-.2ML</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Sigma-Aldrich</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">mouse</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Alexa 488</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Secondary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">A-11001</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ThermoFisher Scientific</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:200 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Goat</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MHC IIa (fast)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">NCL-MHCf</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Leica </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:40</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">GLUT-4</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PA5-23052</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Fisher Scientific</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">AMPK-α</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2532S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Phospho (Thr172)-AMPK-α</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2535S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CaMKII</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">4436S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Phospho (Thr286)-CaMKII</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">12716</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Akt</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9272S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Phospho (Ser473)-Akt</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9271S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">AS160</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2447S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Phospho (Thr642)-AS160</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">4288S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Hexokinase II</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2106S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Glycogen Synthase (GS)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3893S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Phosphor (Ser641)-GS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3891S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">IRS-1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2390S</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phospho (Tyr895)-IRS-1</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary antibody</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3070S</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell Signaling</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1:1000</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rabbit</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
